A phase II clinical study of interleukin-11 mutein to treat patients with chemotherapy-induced thrombocytopenia. Background: The aim of this prospective, double-blind study was to evaluate sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback